Akum Pharma Gets CDSCO Panel Nod to Study Cetirizine Ophthalmic Solution Dr. Divya Colin9 Oct 2023 6:00 PM ISTNew Delhi: The drug major Akum Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
CDSCO panel opines Sun Pharma to submit more safety data of Ranibizumab Solution for Injection Dr. Divya Colin8 Oct 2023 6:00 PM ISTNew Delhi: Responding to the proposal presented by the pharmaceutical major Sun Pharma for approval of additional indications for the already approved...
Evaluate safety in proposed study: CDSCO Panel tells Syngene on Suplatast Tosilate Capsule Dr. Divya Colin7 Oct 2023 6:00 PM ISTNew Delhi: Approving the proposal presented by Syngene International to conduct a Phase II clinical trial of Suplatast Tosilate 100mg Capsule, the...
Include more Govt sites: CDSCO Panel Tells Glenmark on Asthma Drug Combination Dr. Divya Colin6 Oct 2023 6:00 PM ISTNew Delhi: Citing that more government sites shall be included in the study with geographical distribution, the Subject Expert Committee (SEC)...
Zydus Healthcare gets CDSCO Panel Nod To Manufacture, Market Dydrogesterone Extended Release Tablet Dr. Divya Colin5 Oct 2023 6:00 PM ISTNew Delhi: The drug major Zydus Healthcare has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Drug Safety Alert: Indian Pharmacopoeia Commission Flags ADR Linked To GERD drug Esomeprazole Susmita Roy4 Oct 2023 6:00 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of September, has revealed that...
Akums Gets CDSCO Panel Nod to Study Cilnidipine, Telmisartan FDC film-coated tablet Dr. Divya Colin3 Oct 2023 6:00 PM ISTNew Delhi: The drug major Akum Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Sun Pharma Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC Drug Dr. Divya Colin2 Oct 2023 6:00 PM ISTNew Delhi: Pharmaceutical major Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Submit BE study, Phase III trial protocol: CDSCO panel tells Glenmark on Metformin, Glimepiride, Lobeglitazon FDC Susmita Roy1 Oct 2023 6:00 PM ISTNew Delhi: Citing the proposed fixed-dose combination (FDC) is not approved internationally, the Subject Expert Committee (SEC) functional under the...
Sun Pharma Gets CDSCO Panel Nod To Market Sitagliptin, Metformin, Glimepiride FDC in Lower Strength Dr. Divya Colin30 Sept 2023 6:00 PM ISTNew Delhi: Pharmaceutical major Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Revise phase III trial protocol: CDSCO Panel tells Bharath Biotech on Inactivated Japanese Encephalitis vaccine Dr. Divya Colin29 Sept 2023 6:00 PM ISTNew Delhi: In response to the proposal presented by vaccine maker Bharath Biotech for a grant of permission to conduct a Phase III clinical trial for...
Provide in-vivo data, global data: CDSCO Panel Tells Glenmark on Pulmonary FDC in Inhalation Suspension Dr. Divya Colin28 Sept 2023 6:00 PM ISTNew Delhi: In reaction to the request for a waiver of bioequivalence (BE) and Phase III clinical trials for the inhalation suspension of the pulmonary...
